Cargando…
Hyperthrombotic Milieu in COVID-19 Patients
COVID-19 infection has protean systemic manifestations. Experience from previous coronavirus outbreaks, including the current SARS-CoV-2, has shown an augmented risk of thrombosis of both macrovasculature and microvasculature. The former involves both arterial and venous beds manifesting as stroke,...
Autores principales: | Kamel, Mohamed Hassan, Yin, Wenqing, Zavaro, Chris, Francis, Jean M., Chitalia, Vipul C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694011/ https://www.ncbi.nlm.nih.gov/pubmed/33142844 http://dx.doi.org/10.3390/cells9112392 |
Ejemplares similares
-
Janus Kinase Signaling Pathway and Its Role in COVID-19 Inflammatory, Vascular, and Thrombotic Manifestations
por: Ravid, Jonathan D., et al.
Publicado: (2022) -
c-Cbl targets PD-1 in immune cells for proteasomal degradation and modulates colorectal tumor growth
por: Lyle, Chimera, et al.
Publicado: (2019) -
A painful lesson from the COVID-19 pandemic: the need for broad-spectrum, host-directed antivirals
por: Chitalia, Vipul C., et al.
Publicado: (2020) -
Bréve: Covid-19 : mesures en milieu scolaire
por: Manus, Jean-Marie
Publicado: (2021) -
End-stage kidney disease and COVID-19 in an urban safety-net hospital in Boston, Massachusetts
por: Kamel, Mohamed Hassan, et al.
Publicado: (2021)